Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex ; volume:15 ; number:1 ; day:1 ; month:6 ; year:2020 ; pages:1-7 ; date:12.2020
Orphanet journal of rare diseases ; 15, Heft 1 (1.6.2020), 1-7, 12.2020
- Urheber
-
Hatano, Takashi
Ohno, Yuki
Imai, Yu
Moritake, Jun
Endo, Katsuhisa
Tamari, Mayumi
Egawa, Shin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-020-01417-5
- URN
-
urn:nbn:de:101:1-2020080322541094512934
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hatano, Takashi
- Ohno, Yuki
- Imai, Yu
- Moritake, Jun
- Endo, Katsuhisa
- Tamari, Mayumi
- Egawa, Shin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sirolimus in Infants with Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex
Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up
Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
Tuberous Sclerosis Complex with Lung Involvement
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
Reviewing 15 years of experience with sirolimus
Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo
Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis
Radiosensitivity in individuals with tuberous sclerosis complex
Topical EMLA Cream as a Pretreatment for Facial Lacerations
Tuberous sclerosis with visceral leishmaniasis: a case report
Sirolimus in Infants with Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex
Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up
Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
Tuberous Sclerosis Complex with Lung Involvement
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
Reviewing 15 years of experience with sirolimus
Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo
Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis
Radiosensitivity in individuals with tuberous sclerosis complex
Topical EMLA Cream as a Pretreatment for Facial Lacerations
Tuberous sclerosis with visceral leishmaniasis: a case report
Sirolimus in Infants with Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex
Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up
Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
Tuberous Sclerosis Complex with Lung Involvement
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model
Reviewing 15 years of experience with sirolimus
Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo
Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis
Radiosensitivity in individuals with tuberous sclerosis complex
Topical EMLA Cream as a Pretreatment for Facial Lacerations